{"schema_version":"secwatch.filing_event.v1","accession":"0001551306-26-000012","form_type":"8-K","ticker":"PGNY","cik":"0001551306","company_name":"Progyny, Inc.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.405540+00:00","generated_at":"2026-05-15T23:34:18.770473+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Progyny Q4 revenue up 6.7% to $318.4M; guides FY2026 revenue $1.355B-$1.405B","bullets":["Q4 revenue $318.4M (+6.7% YoY); FY2025 revenue $1.2887B (+10% YoY); gross margin expanded to 24.1%.","Q4 net income $12.5M ($0.14 diluted EPS); adj. EPS $0.48; adj. EBITDA $51.4M (16.1% margin).","Full year operating cash flow record $210.2M; repurchased 3.3M shares in Q4, 6.5M total under $200M authorization.","FY2026 revenue guidance $1.355B-$1.405B; adj. EBITDA $224M-$239M; adj. EPS $1.83-$1.95.","Client count 555 as of Dec 2025 (up from 473); expects ~600 clients representing ~7.2M covered lives in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001551306-26-000012","json":"https://secwatch.observer/filing/0001551306-26-000012.json","markdown":"https://secwatch.observer/filing/0001551306-26-000012.md","text":"https://secwatch.observer/filing/0001551306-26-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551306/000155130626000012/0001551306-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551306/000155130626000012/pgny-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:34:18.770473+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}